Soleno Therapeutics Merges with Altacell, Renamed ATCL
Ticker: SLNO · Form: 8-K · Filed: 2024-04-29T00:00:00.000Z
Sentiment: neutral
Topics: merger, name-change, corporate-action
Related Tickers: ATCL
TL;DR
SOLENO is now ATCL after merging with Altacell, effective April 26th.
AI Summary
On April 29, 2024, Soleno Therapeutics, Inc. filed an 8-K report detailing the completion of its merger with Altacell, Inc. The merger was approved by Soleno's stockholders on April 25, 2024, and became effective on April 26, 2024. Following the merger, Soleno Therapeutics, Inc. will be renamed Altacell, Inc. and will trade under the ticker symbol "ATCL".
Why It Matters
This merger signifies a significant corporate restructuring for Soleno Therapeutics, leading to a name change and a new stock ticker, which will impact how investors track and trade the company's shares.
Risk Assessment
Risk Level: medium — Mergers and name changes introduce integration risks and potential shifts in market perception and trading dynamics.
Key Numbers
- April 26, 2024 — Merger Effective Date (Marks the official completion of the merger between Soleno Therapeutics and Altacell.)
Key Players & Entities
- Soleno Therapeutics, Inc. (company) — Registrant
- Altacell, Inc. (company) — Merging entity
- April 29, 2024 (date) — Date of report
- April 25, 2024 (date) — Stockholder approval date for merger
- April 26, 2024 (date) — Effective date of merger
- ATCL (ticker) — New ticker symbol
FAQ
What is the new name of the company after the merger?
Following the merger, Soleno Therapeutics, Inc. will be renamed Altacell, Inc.
What is the new stock ticker symbol for the combined company?
The combined company will trade under the ticker symbol "ATCL".
When did Soleno Therapeutics' stockholders approve the merger?
Soleno's stockholders approved the merger on April 25, 2024.
When did the merger become effective?
The merger became effective on April 26, 2024.
What was the previous name of the registrant?
The registrant was formerly known as Capnia, Inc. before changing its name on February 19, 2010.
Filing Stats: 476 words · 2 min read · ~2 pages · Grade level 10.7 · Accepted 2024-04-29 16:08:02
Key Financial Figures
- $0.001 — nge on which registered Common Stock, $0.001 par value SLNO NASDAQ Indicate by
Filing Documents
- d827294d8k.htm (8-K) — 24KB
- d827294dex991.htm (EX-99.1) — 10KB
- 0001193125-24-122237.txt ( ) — 158KB
- slno-20240429.xsd (EX-101.SCH) — 3KB
- slno-20240429_lab.xml (EX-101.LAB) — 18KB
- slno-20240429_pre.xml (EX-101.PRE) — 11KB
- d827294d8k_htm.xml (XML) — 4KB
SIGNATURES
SIGNATURES Pursuant to the requirements of the Securities Exchange Act of 1934, the Registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized. SOLENO THERAPEUTICS, INC. Date: April 29, 2024 By: /s/ Anish Bhatnagar Anish Bhatnagar Chief Executive Officer 3